NEW YORK (GenomeWeb News) — Stem cell therapeutics and research tools firm StemCells said today that it has transferred the Melbourne, Australia-based operations of recently acquired Stem Cell Sciences to StemCells' facilities in Cambridge, UK, and Palo Alto, Calif.

The move is part of StemCells' efforts to streamline operations following its estimated $4.8 million acquisition of SCS, which it originally announced in March and closed on April 1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.